共 21 条
[1]
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2005, 294 (24)
:3108-3116
[2]
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[3]
Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain MI Registry
[J].
JOURNAL OF THE AMERICAN HEART ASSOCIATION,
2018, 7 (24)
[4]
Multivessel Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in ESRD
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2012, 23 (12)
:2042-2049
[5]
Foley RN, 1998, J AM SOC NEPHROL, V9, P267
[6]
Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry
[J].
CIRCULATION,
2010, 121 (03)
:357-U33
[9]
Maini R, 2018, J AM SOC NEPHROL
[10]
Kidney disease as a risk factor for development of cardiovascular disease - A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention
[J].
HYPERTENSION,
2003, 42 (05)
:1050-1065